This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Synergy Pharmaceuticals Inc (SGYP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 18.13M 12.42M 13.24M 1.71M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 20.09M 0.00 0.00
Total Current Assets 71.88M 34.05M 14.31M 2.71M
Property, Plant & Equipment, Gross 692.00K 77.00K 50.54K 50.54K
Accumulated Depreciation & Depletion 103.00K 47.00K 44.76K 42.79K
Property, Plant & Equipment, Net 589.00K 30.00K 5.77K 7.75K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 94.00K 3.33M 1.56M 1.69M
Total Non-Current Assets 683.00K 3.36M 1.56M 1.70M
Liabilities & Shareholder Equity
Total Assets 72.56M 37.40M 15.87M 4.40M
Accounts Payable 13.54M 5.26M 1.42M 2.96M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 15.68M 7.32M 2.75M 5.01M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.53M 5.26M 3.33M 3.49M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.53M 5.26M 3.33M 3.49M
Total Liabilities 17.21M 12.57M 6.07M 8.50M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 55.35M 24.83M 9.80M -4.10M
Common Par 10.00K 7.00K 5.43K 9.22K
Additional Paid In Capital 226.52M 133.88M 79.40M 51.03M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -171.18M -109.05M -69.61M -55.14M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 55.35M 24.83M 9.80M -4.10M
Total Equity 55.35M 24.83M 9.80M -4.10M
Total Liabilities & Stock Equity 72.56M 37.40M 15.87M 4.40M
Total Common Shares Outstanding 90.18M 66.62M 54.28M 46.09M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 85.22M 61.70M 47.60M 44.88M
Diluted Weighted Shares Outstanding 85.22M 61.70M 47.60M 44.88M
Number of Employees 25 18 9 8
Number of Part-Time Employees 0 0 1 2
SGYP News

SGYP Synergy Pharmaceuticals Inc

Analysts Ratings for SGYP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SGYP ANALYST REPORT

Brokerage Partners

SGYP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs